The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part IV: the 1984 coronary primary prevention trial ends it--almost
about
Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversyRegulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinicCholesterol in the retina: the best is yet to come.Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic strokeEvaluation of low-intensity laser radiation on stimulating the cholesterol degrading activity: Part I. Microorganisms isolated from cholesterol-rich materialsCholesteryl ester transfer protein (CETP) I405V polymorphism and cardiovascular disease in eastern European Caucasians - a cross-sectional studyThe "Mevalonate hypothesis": a cholesterol-independent alternative for the etiology of atherosclerosis.Fundamental research is the basis for understanding and treatment of many human diseases.Hyperlipidemia as a risk factor for cardiovascular disease.Advances in the management of hyperlipidemia-induced atherosclerosis.eNOS, metabolic syndrome and cardiovascular disease.Lipid and endothelium-related genes, ambient particulate matter, and heart rate variability--the VA Normative Aging StudyFalse profits and silent partners in health care.Role of tissue factor in atherothrombosis.A case study of single-pill combination therapy: the ezetimibe/simvastatin combination for treatment of hyperlipidemia.Translation gone awry: differences between commonsense and science.Fibrates and niacin: is there a place for them in clinical practice?Statins, Muscle Disease and Mitochondria.
P2860
Q28305315-2CCE25BB-36A5-45D1-8722-CF7A4F38C913Q30498812-2E0B8ACE-3DF8-4AD8-82E0-6977CEB0591BQ33758267-5E472573-C107-4438-80BA-A78723B47035Q34095488-FEA48D69-B5D3-4741-ACE9-F5C8E500ACBFQ34958235-68663F65-139D-45B6-97B0-5FABBF3A97B9Q36083105-C69D51CF-2868-472D-80ED-E3FA32F9D9FEQ36394541-C2919BF9-36D2-4DD2-A776-A6DD064C7DA7Q36522101-A1605BA2-F021-4377-9ED6-095033D307C1Q36609968-1303C768-6FDF-4EB7-A943-9E740F422471Q37104870-B3D7572B-0074-4347-B272-9BD93353A30BQ37317509-D193B5EC-4B31-4F3E-A287-92B5E2A99012Q37604234-9DE2C5F4-CA3A-40DC-8C7C-FF4781736130Q37616119-226E98F6-1632-45A7-96ED-F05492E467E4Q38034092-F6862DE9-29B6-45F9-828D-8746243EAD5CQ38036194-3B2D6ED7-36D0-4A36-9CAB-A93E1F7774E3Q38154115-62BE160A-E308-49B2-80F4-F6D7F432D023Q38260501-777A2453-2AB4-4951-A39A-E5D77B1BF3ECQ41552418-5F5A3183-E6AD-446E-A27F-B683D9C9098C
P2860
The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part IV: the 1984 coronary primary prevention trial ends it--almost
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The pathogenesis of atheroscle ...... evention trial ends it--almost
@ast
The pathogenesis of atheroscle ...... evention trial ends it--almost
@en
The pathogenesis of atheroscle ...... evention trial ends it--almost
@nl
type
label
The pathogenesis of atheroscle ...... evention trial ends it--almost
@ast
The pathogenesis of atheroscle ...... evention trial ends it--almost
@en
The pathogenesis of atheroscle ...... evention trial ends it--almost
@nl
prefLabel
The pathogenesis of atheroscle ...... evention trial ends it--almost
@ast
The pathogenesis of atheroscle ...... evention trial ends it--almost
@en
The pathogenesis of atheroscle ...... evention trial ends it--almost
@nl
P2860
P3181
P1476
The pathogenesis of atheroscle ...... evention trial ends it--almost
@en
P2093
Daniel Steinberg
P2860
P3181
P356
10.1194/JLR.R500014-JLR200
P407
P577
2006-01-01T00:00:00Z